Georgeta V.
- Country
- Romania
- Department
- Diabetes, Nutrition and Metabolic Diseases
Research Overview
- A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- Efficacy and Safety of Eloralintide in Adults With Persistent Obesity or Overweight Treated With a Weekly Incretin: A Phase 3, Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 528 of 920 partner sites.
Specializations
Diabetes Management
Specializes in investigating innovative treatments for Type 2 Diabetes Mellitus, with particular focus on glycemic control optimization through novel therapeutic approaches.
- Oral glucose-lowering medications
- GLP-1 receptor agonists
- Insulin therapy optimization
Explores transitions between different therapeutic options for enhanced diabetes management outcomes.
Cardiometabolic Health
Focuses on the intersection of cardiovascular disease prevention and metabolic disorders, particularly in high-risk populations.
- Atherosclerotic cardiovascular disease prevention
- Major adverse cardiovascular events reduction
- Cardiovascular risk management
Investigates therapeutic strategies for comprehensive cardiometabolic risk reduction.
Metabolic Disorders
Specializes in treating complex metabolic conditions, particularly focusing on the relationship between obesity and diabetes.
- Weight management in diabetes
- Metabolic syndrome
- Chronic kidney disease management
Evaluates integrated approaches for managing multiple metabolic conditions simultaneously.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.